How big is the Thrombin Market | Insights, Forecast & Analysis 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA9362

Publication Date: Sep 2025

How big is the Thrombin Market

According to 6Wresearch internal database and industry insights, the Global Thrombin Market was valued at USD 0.5 Billion in 2024 and is expected to reach USD 0.8 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Thrombin Market.

View Main Report Schedule Analyst Call

The primary drivers of growth in the Thrombin Market are the rising incidence of surgeries, increased demand for haemostatic agents, advancements in thrombin formulations, and expanding use in minimally invasive surgeries across a variety of healthcare applications.

Growth Factors for Thrombin Industry

A rising number of surgical interventions is driving demand for effective haemostatic products
Increased utilisation of thrombin for wound management and trauma care
Progress in recombinant and plasma-derived thrombin formulations
Growing applications in minimally invasive surgery and orthopaedic procedures
Enhanced awareness among healthcare providers of advanced surgical haemostats

Thrombin Market Trends

Trends in the thrombin market indicate an upward usage in surgical and trauma settings due to its effectiveness in bleeding control. Recombinant thrombin is increasingly becoming a popular choice for its safer profile compared to plasma-derived thrombin. Market participants are working through next-generation delivery systems and simplified designs to provide a wider selection of products for customers. Increased healthcare spending and focus on exact surgical care are also contributing to the growing use of thrombin across various medical specialties.

Emerging Developments in the Thrombin Market

Thrombin market developments include advancements in biotechnology that facilitate better recombinant products with a lower risk of immunogenicity. Companies are investing money into innovative packaging and pre-filled applicators to maximize efficiency for surgeons. Expanding into wound management and chronic care is broadening the scope of thrombin use. Finally, collaborations between pharmaceutical organizations and healthcare systems are supporting better access and consistent availability of thrombin in practice.